Precision medicine - Company finances
|
EUR
|
2025
From: 2025-10-30
To: 2025-12-31
|
|---|---|
|
Financial data
|
|
| Sales revenue | 4,771 |
| Profit before tax | - |
| Net profit | -1,787 |
| Equity | -787 |
| Liabilities | 10,052 |
| Non-current assets | 0 |
| Current assets | 9,129 |
| Total assets | 9,129 |
|
Taxes paid
|
|
| STI taxes | 870 |
|
Financial indicators
|
|
| Revenue change y/y | - |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -19.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -37.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 4,771 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Precision medicine - Social security debts
The company had no debts to Sodra
Precision medicine - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-03-28 | 2026-04-01 | 7980.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.